Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone

CONTEXT: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy has demonstrated an improved metabolic profile compared to conventional 3-times-daily (TID-HC) therapy among patients with primary adrenal insufficiency. This effect might be related to a more physiological cortisol pro...

詳細記述

保存先:
書誌詳細
出版年:J Clin Endocrinol Metab
主要な著者: Espiard, Stéphanie, McQueen, Johanna, Sherlock, Mark, Ragnarsson, Oskar, Bergthorsdottir, Ragnhildur, Burman, Pia, Dahlqvist, Per, Ekman, Bertil, Engström, Britt Edén, Skrtic, Stanko, Wahlberg, Jeanette, Stewart, Paul M, Johannsson, Gudmundur
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Clinical Research Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947853/
https://ncbi.nlm.nih.gov/pubmed/33236103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa862
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料